medRxiv

Parkinson’s case counts varied by method in UK Biobank

Hospital and death records identified about 20% fewer Parkinson’s cases than a drug-based method over 15 years of follow-up.

Upright, faceless people form a large group above several record sheets and a smaller group above a single sheet.

Our read

Biomarkers
Studied:
Preprint: cohort study of UK Biobank participants, 15 years of follow-up, against a drug-based method
What changed:
Hospital and death records identified about 20% fewer Parkinson's cases than a drug-based method over 15 years of follow-up
The catch:
Primary care records covered about 45% of participants, limiting the drug-based method

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

UK Biobank participants were studied in an observational comparison of three ways to identify Parkinson’s disease. Researchers compared hospital and death records with general practitioner diagnoses and a new method using drug records.

Hospital and death records dated diagnosis a median 4.2 years after Parkinson’s drugs were started. They underestimated disease incidence by 36% compared with UK reference rates, while the drug-based method yielded rates consistent with those references. Estimates of links with sex, walking speed and mortality also differed between these methods. General practitioner diagnoses and the drug-based method yielded similar findings. However, both diagnosis-based approaches included people with other causes of Parkinson’s-like movement symptoms.

Why it matters

For research on Parkinson’s disease, an age-related disorder, the authors suggest combining data sources to improve the validity of studies of disease risk and mortality.

Caveats

Primary care records covered about 45% of participants, limiting where the drug-based method could be applied within UK Biobank. The preprint has not been peer-reviewed.

Comments

Be the first to comment.